Logo

American Heart Association

  34
  0


Final ID:

Clinical Implications, Mechanisms and Public Health Strategies in Cardiovacular Disease

  • Martin, Kathleen  ( YALE SCHOOL OF MEDICINE , New Haven , Connecticut , United States )
  • Musunuru, Kiran  ( University of Pennsylvania , Philadelphia , Pennsylvania , United States )
  • Creager, Mark  ( Dartmouth-Hitchcock , Lebanon , New Hampshire , United States )
  • Pradhan, Aruna  ( Brigham and Women's Hospital , Boston , Massachusetts , United States )
  • Author Disclosures:
    Kathleen Martin: DO NOT have relevant financial relationships | Kiran Musunuru: DO have relevant financial relationships ; Individual Stocks/Stock Options:Verve Therapeutics:Active (exists now) ; Research Funding (PI or named investigator):Beam Therapeutics:Active (exists now) ; Research Funding (PI or named investigator):Nava Therapeutics:Active (exists now) ; Advisor:Capstan Therapeutics:Active (exists now) ; Advisor:LEXEO Therapeutics:Active (exists now) ; Ownership Interest:Variant Bio:Active (exists now) ; Advisor:Verve Therapeutics:Active (exists now) | Mark Creager: DO NOT have relevant financial relationships | Aruna Pradhan: No Answer
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Vascular Calcification and Gene-editing Therapy in Peripheral and Cardiovascular Disease

Monday, 11/10/2025 , 01:30PM - 02:45PM

Cardiovascular Seminar

More abstracts on this topic:
More abstracts from these authors:
You have to be authorized to contact abstract author. Please, Login
Not Available